Catalyst Biosciences Announces Agreement to Sell NNR Asset For $750K, With Potential To Receive $337M In Development, Regulatory, and Commercial Milestone Payments
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.